Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Corticosteroids in the treatment of severe nocardia pneumonia in chronic granulomatous disease.

Freeman AF, Marciano BE, Anderson VL, Uzel G, Costas C, Holland SM.

Pediatr Infect Dis J. 2011 Sep;30(9):806-8. doi: 10.1097/INF.0b013e318218181d.

2.

Glucocorticosteroids: current and future directions.

Barnes PJ.

Br J Pharmacol. 2011 May;163(1):29-43. doi: 10.1111/j.1476-5381.2010.01199.x. Review.

3.

Residual NADPH oxidase and survival in chronic granulomatous disease.

Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, Uzel G, DeRavin SS, Priel DA, Soule BP, Zarember KA, Malech HL, Holland SM, Gallin JI.

N Engl J Med. 2010 Dec 30;363(27):2600-10. doi: 10.1056/NEJMoa1007097.

4.

PPARĪ³ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease.

Fernandez-Boyanapalli R, Frasch SC, Riches DW, Vandivier RW, Henson PM, Bratton DL.

Blood. 2010 Nov 25;116(22):4512-22. doi: 10.1182/blood-2010-02-272005. Epub 2010 Aug 6.

5.

Tryptophan/kynurenine metabolism in human leukocytes is independent of superoxide and is fully maintained in chronic granulomatous disease.

De Ravin SS, Zarember KA, Long-Priel D, Chan KC, Fox SD, Gallin JI, Kuhns DB, Malech HL.

Blood. 2010 Sep 9;116(10):1755-60. doi: 10.1182/blood-2009-07-233734. Epub 2010 May 28.

6.

NADPH oxidase limits innate immune responses in the lungs in mice.

Segal BH, Han W, Bushey JJ, Joo M, Bhatti Z, Feminella J, Dennis CG, Vethanayagam RR, Yull FE, Capitano M, Wallace PK, Minderman H, Christman JW, Sporn MB, Chan J, Vinh DC, Holland SM, Romani LR, Gaffen SL, Freeman ML, Blackwell TS.

PLoS One. 2010 Mar 16;5(3):e9631. doi: 10.1371/journal.pone.0009631.

7.

Hypersensitivity pneumonitis.

Girard M, Lacasse Y, Cormier Y.

Allergy. 2009 Mar;64(3):322-34. doi: 10.1111/j.1398-9995.2009.01949.x. Epub 2009 Feb 6. Review.

8.

Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease.

Marks DJ, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW.

Am J Gastroenterol. 2009 Jan;104(1):117-24. doi: 10.1038/ajg.2008.72.

PMID:
19098859
9.

ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease.

Brown KL, Bylund J, MacDonald KL, Song-Zhao GX, Elliott MR, Falsafi R, Hancock RE, Speert DP.

Clin Immunol. 2008 Oct;129(1):90-102. doi: 10.1016/j.clim.2008.06.005. Epub 2008 Jul 26.

PMID:
18676204
10.

Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.

Feld JJ, Hussain N, Wright EC, Kleiner DE, Hoofnagle JH, Ahlawat S, Anderson V, Hilligoss D, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T.

Gastroenterology. 2008 Jun;134(7):1917-26. doi: 10.1053/j.gastro.2008.02.081. Epub 2008 Mar 4.

11.

Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.

Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, Zelante T, Vacca C, Bistoni F, Fioretti MC, Grohmann U, Segal BH, Puccetti P.

Nature. 2008 Jan 10;451(7175):211-5. doi: 10.1038/nature06471.

PMID:
18185592
12.

Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease.

Siddiqui S, Anderson VL, Hilligoss DM, Abinun M, Kuijpers TW, Masur H, Witebsky FG, Shea YR, Gallin JI, Malech HL, Holland SM.

Clin Infect Dis. 2007 Sep 15;45(6):673-81. Epub 2007 Aug 8.

PMID:
17712749
13.

Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B.

Bylund J, MacDonald KL, Brown KL, Mydel P, Collins LV, Hancock RE, Speert DP.

Eur J Immunol. 2007 Apr;37(4):1087-96.

14.

Hepatic abnormalities in patients with chronic granulomatous disease.

Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, Koziel DE, Anderson V, Hilligoss D, Choyke P, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T.

Hepatology. 2007 Mar;45(3):675-83.

PMID:
17326162
15.

Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature.

Yamazaki-Nakashimada MA, Stiehm ER, Pietropaolo-Cienfuegos D, Hernandez-Bautista V, Espinosa-Rosales F.

Ann Allergy Asthma Immunol. 2006 Aug;97(2):257-61.

PMID:
16937761
16.

Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease.

Lekstrom-Himes JA, Kuhns DB, Alvord WG, Gallin JI.

J Immunol. 2005 Jan 1;174(1):411-7.

17.

Gastrointestinal involvement in chronic granulomatous disease.

Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O'Brien S, Hilligoss DM, Malech HL, Gallin JI, Holland SM.

Pediatrics. 2004 Aug;114(2):462-8.

PMID:
15286231
18.

Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease.

Kobayashi SD, Voyich JM, Braughton KR, Whitney AR, Nauseef WM, Malech HL, DeLeo FR.

J Immunol. 2004 Jan 1;172(1):636-43.

19.

Underlying chronic granulomatous disease in a patient with bronchocentric granulomatosis.

Moltyaner Y, Geerts WH, Chamberlain DW, Heyworth PG, Noack D, Rae J, Doyle JJ, Downey GP.

Thorax. 2003 Dec;58(12):1096-8.

20.

Hepatic abscess in patients with chronic granulomatous disease.

Lublin M, Bartlett DL, Danforth DN, Kauffman H, Gallin JI, Malech HL, Shawker T, Choyke P, Kleiner DE, Schwartzentruber DJ, Chang R, DeCarlo ES, Holland SM.

Ann Surg. 2002 Mar;235(3):383-91.

Supplemental Content

Support Center